Plasma concentrations of free amyloid β cannot predict the development of Alzheimer's disease

Biomarkers that identify individuals at risk of Alzheimer’s disease (AD) development would be highly valuable. Plasma concentration of amyloid β (Aβ)—central in the pathogenesis of AD—is a logical candidate, but studies to date have produced conflicting results on its utility.

from Dementia Big http://ift.tt/2j3DvZL via alcoholic dementia

http://ift.tt/2jgtJCS